Tesamorelin for Sale — Buyer Guide 2026
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog studied for visceral fat reduction. Before purchasing from research vendors, verify batch-linked COAs confirming ≥98% purity via HPLC/MS, research-use-only labeling without human-health claims, and transparent third-party testing documentation.
Midwest Peptide
10% off with code SQUARETABLE10 · 30-day cookie · 10% recurring commission
What Tesamorelin Is
Tesamorelin is a 44-amino-acid synthetic peptide that mimics endogenous growth hormone-releasing hormone. It was developed and FDA-approved (as Egrifta) for HIV-associated lipodystrophy. In the research market, it is sold by peptide vendors for laboratory study — not for human consumption. Understanding the distinction between clinical approval and research-market availability is critical for informed vendor evaluation.5 Checks Before Buying
- Third-party COA (batch-linked): The vendor should publish a certificate of analysis from an independent lab — not a self-issued document — with a batch/lot number that matches the product listing.
- Purity confirmed ≥98%: Look for HPLC chromatograms or mass spectrometry data, not just a stated percentage. The raw data should be visible.
- Research-use-only labeling: Vendors explicitly marketing for human use (dosing guides, injection instructions, before-and-after photos) violate FDA research-chemical boundaries and risk seizure.
- Transparent payment and shipping: Legitimate research vendors accept business payment methods, provide tracking, and state clear refund/replacement policies.
- Source dating: COAs and test results should be dated and regularly updated — older than 12 months means the current batch may not have been tested.
Vendor Evaluation Table
| Vendor | COA / Testing Signal | Transparency Score | Risk Level |
|---|---|---|---|
| Peptide Partners | Four-lab roster + contaminant-panel archive | 78/100 · S tier | Low |
| OROS Research | ISO 17025 lab + per-lot testing posture | 75/100 · S tier | Low |
| Pure Peptides | Product-level MZ Biolabs COAs | 73/100 · A tier | Low |
| Crush Research | Four named labs + multi-vial methodology claim | 70/100 · A tier | Medium |
| Kimera Chems | Live COA archive + ISO 17025 lab partner signal | 70/100 · A tier | Medium |
| Elite Research USA | Per-product COAs + three named labs | 70/100 · A tier | Medium |
Seed evaluation from Matt's Reptides intake. Each claim should be re-verified against primary sources before final publication.
Red Flags That Mean Walk Away
Vendors to avoid: any tesamorelin seller offering dosing protocols, human-use instructions, injection guides, or before-and-after photos. Vendors without publicly accessible COAs, those refusing to share batch numbers, and sellers using outcome-based marketing (visible muscle changes, fat-loss guarantees) are outside the research-chemical boundary. Peer-to-peer marketplace sellers (eBay, Reddit DMs, Facebook groups) carry counterfeiting and legal risk.Frequently Asked Questions
Is tesamorelin FDA-approved?
Tesamorelin acetate (Egrifta SV) received FDA approval in 2010 for reducing excess abdominal fat in HIV patients with lipodystrophy. Research-market tesamorelin is sold as a chemical — not as the approved pharmaceutical product. The two should not be conflated.
How do I verify a tesamorelin COA?
A legitimate COA should come from an ISO-accredited independent laboratory, include batch/lot numbers matching the product listing, show HPLC chromatograms or MS spectra (not just a number), and be dated. Verify the lab exists independently and the report is accessible without login gates.
What purity level should I expect?
Research-grade tesamorelin from reputable vendors typically tests at ≥98% purity via HPLC analysis. Anything below 97% should trigger additional scrutiny. Purity alone does not indicate safety — counterfeits can include adulterants that pass basic purity checks.
Is it legal to buy tesamorelin for research?
Research chemical vendors operate under the premise that products are sold for laboratory research only — not human consumption. Federal and state regulations vary. Consult legal counsel for jurisdiction-specific guidance. This page does not provide legal advice.
How much does tesamorelin cost from research vendors?
Research-vendor pricing varies based on quantity, purity claims, and testing documentation. As of mid-2026, prices range approximately $50–$150 per vial depending on the vendor and product specifications. Higher price does not automatically mean higher quality — always verify testing documentation independently.
Related Pages
Peptide Vendor Rankings → · How to Read a COA → · Our Evaluation Methodology →
Verification Notes for Tesamorelin for Sale — Buyer Guide 2026
This file is reviewed as part of the The Peptide Reviewer documentation system, which means the page is not judged by headline confidence alone. The desk checks whether the claim has a date, whether the source can be opened by a reader, whether commercial language is separated from editorial scoring, and whether a medical or regulatory boundary is visible before the reader reaches any vendor context.
For tesamorelin for sale, the practical standard is source literacy. A reader should be able to trace the page back to primary records, compare those records with the current vendor or compound claim, and see what the page does not prove. If a vendor changes a COA, removes a lab report, edits a product page, or adds health-outcome language after this review date, the conclusion can change. That is why this publication keeps source dates, correction rules, and reviewer scope close to the article body instead of hiding them in a footer.
The editorial team uses the same baseline checks across peptide vendor reviews, compound explainers, comparison pages, trust pages, and author pages. First, the page must identify the entity or topic clearly. Second, it must point readers toward primary-source verification. Third, it must avoid personal-use instructions and medical recommendations. Fourth, it must disclose when affiliate economics could exist and state that payment does not change scoring, inclusion, risk labels, or rank order.
When the page discusses a compound, the review separates published research context from research-market product claims. Published studies, trial records, or regulatory documents can describe a molecule, but they do not verify a private vendor batch. When the page discusses a vendor, the review separates a vendor's public marketing from documentation that can be checked, including batch-linked certificates, lab identity, source dates, claims language, and correction history.
Readers should treat this file as an audit trail, not a shortcut. The safest way to use it is to open the listed sources, confirm the current date on the vendor or regulatory record, and compare that source with the page summary. If the source and summary disagree, the source wins until the page is corrected. If the source cannot be found, the claim should be treated as unverified.
This added review note also gives crawlers and readers the same context that the editors use internally: what kind of evidence matters, which trust pages govern the file, who owns the review boundary, and where a correction should start. That matters most on author, policy, and directory pages because those pages can look thin even when they carry important E-E-A-T signals. The added context makes the page auditable without turning it into a new article.
- PubMed for published biomedical literature and review context.
- ClinicalTrials.gov for registered trial status and study records.
- FDA for approval status, warning letters, labeling, and regulatory context.
Frequently Asked Questions
How should I verify this page?
Start with the date, then open the primary source rather than relying on a summary. For medical or regulatory context, check PubMed, ClinicalTrials.gov, and FDA records. For vendor context, check the live vendor page, the batch-linked COA, the named lab, and any archived claim record.
Does this page provide medical advice?
No. The Peptide Reviewer publishes editorial source checks and market-transparency reviews. It does not provide treatment advice, dosing protocols, cycles, stacks, injection instructions, reconstitution guidance, diagnosis help, or personal-use recommendations.
Can affiliate relationships change the conclusion?
No. Affiliate relationships, sponsored links, and referral economics do not change scoring, inclusion, rank position, risk labels, author attribution, or medical-review status. Any paid link must be disclosed before the link and marked with sponsored nofollow attributes.
What happens if a source changes?
The page should be updated through the corrections process. A new COA, a changed vendor claim, an FDA update, or a corrected trial record can change the page. Until that update is made, readers should trust the current primary source over the older summary.
Related Standards
Methodology → · Editorial Standards → · Medical Review Policy → · Corrections Policy → · Affiliate Disclosure →